Anthropic in $30B+ Talks at $900B as Cerebras IPO Pops 68%
In a single week, AI capital markets produced two structural milestones. Anthropic is in early talks to raise at least $30 billion at a $900 billion valuation — which would be the largest single funding round in AI history. Simultaneously, Cerebras Systems made its Nasdaq debut priced at $185 per share, above its expected $150–160 range, and surged 68% on day one to reach a $95 billion market cap.
What the Source Actually Says
TechSnif's weekly digest (May 10–17), citing Bloomberg on Anthropic and CNBC and the Wall Street Journal on Cerebras, frames both events inside a single structural shift: frontier-lab capital has moved from discrete funding rounds to what the newsletter calls continuous flow. Anthropic's $30B+ raise follows OpenAI's $6.6 billion secondary share sale in October 2025 — where over 75 employees hit the individual $30 million cash-out cap — suggesting that at scale, top frontier labs now operate closer to perpetual primary issuers than venture-backed startups. The newsletter's framing: "the AI capital arms race isn't slowing down; it's going exponential."
Cerebras priced above range and raised at least $5.55 billion, with a fully diluted valuation of $56.4 billion on pricing day. The 68% first-day pop left significant investor demand unrealised — read as either intentional demand-warmth signalling or a systematic underread of institutional appetite for AI-chip alternatives. The listing matters beyond the numbers: Cerebras is the first dedicated AI-chip pure-play to go public, giving investors a structural non-NVIDIA vector into AI hardware for the first time.
Context from the same week reinforces how capital is concentrating. Anduril closed a $5 billion Series H at a $61 billion valuation — more than double its $30.5 billion from June 2025 — led by Thrive Capital and a16z. Thrive also co-invested in Isomorphic Labs' $2.1 billion Series B (Alphabet-backed AI drug discovery), the largest non-frontier-lab AI round of the week, per The VC Corner.
Strategic Take
Anthropic at $900B and Cerebras at $95B redefine the capital stratum for frontier AI infrastructure. For operators evaluating model-provider relationships and AI-chip procurement, both commitments now carry sovereign-scale switching costs embedded in their valuations. Thrive Capital's presence across Anduril, Isomorphic Labs, and Anthropic's financing circle in the same week signals where tier-1 venture conviction is concentrating: vertical AI-for-science and defense, not horizontal LLM plays.
